Skip to main content
ARIX BIOSCIENCE PLC logo

ARIX BIOSCIENCE PLC — Investor Relations & Filings

Ticker · ARIX ISIN · GB00BD045071 LEI · 213800OVT3AHQCXNIX43 IL Financial and insurance activities
Open in API
Filings indexed 547 across all filing types
Latest filing 2021-04-06 Transaction in Own Shar…
Country GB United Kingdom
Listing IL ARIX

About ARIX BIOSCIENCE PLC

https://www.arixbioscience.com/

Arix Bioscience plc is a global venture capital company that specializes in the biotechnology and life sciences sectors. The firm's primary activity involves investing in and building innovative biotech companies, providing capital and strategic support from early stages, including seed, preclinical, and clinical development. Arix focuses on identifying and nurturing breakthrough advances in life sciences to accelerate the development of new medical technologies and therapies. According to public information, the company has entered into a process of liquidation.

Recent filings

Filing Released Lang Actions
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states 'Transaction in own shares' in the title and body. It details the purchase of ordinary shares by Arix Bioscience plc as part of a 'buyback programme', including the date, volume, and price of the transactions. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The document also contains metadata fields explicitly listing 'Category Code: POS' and 'OAM Categories: 2.4. Acquisition or disposal of the issuer's own shares', confirming the classification.
2021-04-06 English
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states 'Transaction in own shares' in the title and body. It details the purchase of ordinary shares as part of a 'buyback programme', including the date, volume, and price paid per share. The metadata section also contains 'Category Code: POS' and the final table includes 'Category Code: POS' and 'OAM Categories: 2.4. Acquisition or disposal of the issuer's own shares'. This directly corresponds to the definition for Transaction in Own Shares (POS).
2021-04-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document announces the 'Total Voting Rights' of Arix Bioscience plc as of a specific date (31 March 2021), referencing compliance with 'Disclosure Guidance and Transparency Rules' and providing the total number of ordinary shares with voting rights. This type of mandatory disclosure regarding the total number of shares and voting rights is a specific regulatory announcement. Reviewing the definitions, this content most closely aligns with the category covering changes in significant share ownership or voting rights calculations, which is covered by Major Shareholding Notification (MRQ) or, more generally, Regulatory Filings (RNS). Since the document explicitly states the 'Category Code: TVR' (Total Voting Rights) and falls under 'OAM Categories: 2.5. Total number of voting rights and capital', it is a specific regulatory update. While MRQ deals with *changes* in major holdings, this document provides the *total* baseline figure used for those calculations. Given the options, and its nature as a mandatory regulatory disclosure that doesn't fit perfectly into the other specific categories (like DIV, DIRS, or SHA), RNS (Regulatory Filings) is the most appropriate general classification for this type of routine regulatory update, although it is very close to the scope of MRQ. However, since it is a direct announcement of the total voting rights figure, which is a key component of transparency rules, and it is short and disseminated via a regulatory news service (EQS), RNS is the safest fallback if a more specific code isn't available. Let's re-evaluate the options: DVA is for voting *results*. MRQ is for *changes* in major shareholdings. This is a baseline total. Given the options, RNS (Regulatory Filings) is the best fit for a routine, mandatory disclosure of this nature that doesn't fit the other specific codes.
2021-04-01 English
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states 'Transaction in own shares' in the title and body. It details the purchase of ordinary shares by Arix Bioscience plc as part of a 'buyback programme', including the date, volume, and price of the transactions. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). Although it is disseminated as a Regulatory Announcement (RNS), the core content is about share repurchase, making POS the most specific and accurate classification.
2021-03-31 English
Transaction in own shares
Transaction in Own Shares Classification · 1% confidence The document explicitly states its subject matter in the title and body: "Transaction in own shares". It details the purchase of 85,000 ordinary shares as part of a buyback programme, including the date, volume, and price of individual trades. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The metadata also lists 'Category Code: POS' and 'OAM Categories: 2.4. Acquisition or disposal of the issuer's own shares', confirming this classification.
2021-03-30 English
Arix leads $152 million Series B financing for Pyxis Oncology
Share Issue/Capital Change Classification · 1% confidence The document is a press release dated March 30, 2021, announcing that Arix Bioscience plc led a $152 million Series B financing round for Pyxis Oncology. This announcement details a significant investment and capital raising activity involving the company and its portfolio. This clearly falls under the category of updates on company fundraising, financing activities, or capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS) given the specific nature of the content.
2021-03-30 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.